2nd Annual International Health Finance Forum

Health Insurance Reform · Health Payment Innovation

12.01.2018 — 12.02.2018 · Shanghai

  • 00 days
  • 00 hours
  • 00 minutes
  • 00 seconds

FORUM  OVERVIEW

FORUM  OVERVIEW

This Forum will focus on the development of social health insurance innovation, as well as the impacts and opportunities this presents in other related areas of healthcare. This was chosen as the theme of the Forum as it is hottest topic in healthcare financing, and provides a means of examining the funding and financing of the entire healthcare industry chain. Conference content will include interpretation and trends associated with insurance reform, commercial insurance product innovation, healthcare service model upgrades spurred by payments innovation, value-based treatment, elder care financing, finance technology and other hot-button issues. The Forum will invite key foreign innovators to share their international experience, identify current market demands and collaborate with local enterprises to uncover the best solutions.

This Forum will focus on the development of social health insurance innovation, as well as the impacts and opportunities this presents in other related areas of healthcare. This was chosen as the theme of the Forum as it is hottest topic in healthcare financing, and provides a means of examining the funding and financing of the entire healthcare industry chain. Conference content will include interpretation and trends associated with insurance reform, commercial insurance product innovation, healthcare service model upgrades spurred by payments innovation, value-based treatment, elder care financing, finance technology and other hot-button issues. The Forum will invite key foreign innovators to share their international experience, identify current market demands and collaborate with local enterprises to uncover the best solutions.

0
Sessions
0 +
Speakers
0 +
Attendance

SPEAKER

Policy Experts

Academia Scholars

Pharmaceutical Company Executives

Healthcare Services Industry Professionals

Insurance Company Leaders

Healthcare Startup CEOs

FORUM

AGENDA

Dec.01_Part I

Dec.01_Part I

09:00-09:20 Opening Remarks

Dinesh Nair Senior Health Specialist, World Bank
Chang LIU Managing Director ACCESS Health International Singapore, Mainland China and Hong Kong

Session 1: Health Insurance Reform:International and Domestic Experience Sharing

09:20-09:40 Keynote Speech:
Perfecting the Construction of a Multi-layered Health Insurance System

Jin FANG Deputy Secretary General, China Development Research Foundation

09:40-10:00 Keynote Speech:
Achieving Health Insurance Reform and Value-based Healthcare Implementation

Chunlin JIN Director Shanghai Health Development Research Center
(Shanghai Medical Technology Intelligence Institute)

10:00-10:15 Keynote Speech:
Universal Health Insurance Coverage

Eduardo P. Banzon Principal Health Specialist, Sustainable Development and Climate Change Department Asian Development Bank (ADB)

10:30-10:45 Keynote Speech:
Medicine Access Policy around the globe:Experience and Challenges for China

Silver CHEN Senior Director, Regional Access Lead – APAC/China at Pfizer

10:45AM - Tea Break
Session 2:Health Payment Innovation and Health Service System Upgrade

10:45-11:00 Keynote Speech:
Payment Innovation Promotes Chinese Health Service System Upgradation

Weiping GUO Chief Executive Officer and Executive Director, Universal Medical

11:00-11:15 Keynote Speech:
Experience Sharing:Healthcare System in Singapore

Jeremy LIM Partner & Head of Health & Life Sciences, Oliver Wyman, Asia Pacific, Chair of the Steering Committee for NIHA(NUS Initiative to Improve Health in Asia)

11:15-11:30 Keynote Speech:
Experience sharing:Taiwan's National Health Insurance and its Single-Payer System

Jui-fen Rachel Lu Professor, Chang Gung University

11:30-12:15 Roundtable:
How Can Commercial Health Insurance better Complement Social Insurance?

Wenkai LI Director and Chief Representative, China Medical Board (CMB) in Beijing Office
Zhen WANG Director, Department of Public Economics; Deputy Director, Center for Public Policy Research for Chinese Academy of Social Sciences (CASS)
Joshua Kurtzig Vice President for Healthcare Partnerships,United Family Healthcare
Lei LI General Manager,Strategic Operations Department of PKU Healthcare Group
Fujie XU Professor, The First Affiliated Hospital, Zhejiang University

12:15 - Lunch
Dec.01_Part2

Dec.01_Part2

14:00-14:15 Opening Remarks

Dawei LIU Board Secretary, Vice President, Joint Company Secretary,Shanghai Pharmaceuticals Holding Co.,ltd.

Session 3: Promotion of Innovation in health Finance and pharmaceutical industry

14:15-14:30 Keynote Speech:
Innovation and Upgrade of Health Financing under the backdrop of Health Insurance Reform

Xiaoyan XIA Partner& Managing Director,The Boston Consulting Group (BCG)

14:30-15:30 Roundtable:
With a focus on Health Financing and multi-channel collaboration to promote better Payment System for Patients

Xiaoyan XIA Partner& Managing Director,The Boston Consulting Group (BCG)
Jim Maritan Senior Advisor, Shanghai MediTrust Health Co.,Ltd. Former CVS Vice President
Yi LIANG Chief Bussiness Officer& President of the Great China Region,Zai Lab Limited
Shaofeng CHEN Vice President, Business Unit Oncology 2,Roche
Xudong FU President of China Market Access,Bristol-Myers Squibb
Wang SHI Managing Director - MSD China Regional Operations
Xiaojun SHAO Chief Medical Officer,China Pacific Insurance (Group) Co. Ltd.

3:50 - Tea Break

Session 4: Commercial Insurance Innovation and the Establishment of the Muti-layered Health Insurance System

15:30-15:45 Keynote Speech:
TBD

Jim Maritan Senior Advisor, Shanghai MediTrust Health Co.,Ltd. Former CVS Vice President

15:10-16:25 Keynote Speech:
Cooperation between Commercial Insurance Companies and Pharmaceutical Firms

Chu ZHANG Deputy General Manager, Actuarial Department, China Life Reinsurance Company Limited

16:25-17:15 Roundtable:
How can Commercial Insurance in China Supplement and Support Social Health Insurance to provide Universal and Affordable Healthcare?

Chu ZHANG Deputy General Manager, Actuarial Department, China Life Reinsurance Company Limited
Yan LI Chief Actuary, Huaxia Life Insurance Co., Ltd.
Shaohua CAO OP BU Head Eli Lilly and Company
Quanhua SONG Vice president Government & Corporate Business, China Pacific Life Insurance Co, Ltd. , President, Pacific Medical& Health Management Co, Ltd
Jiakang ZHU Franchise Head of Lung Cancer, Oncology BU at Astrazeneca
Baiyan CAO Chief Executive Officer& IOA,Jianyi Information technology Co. Ltd.

17:15-17:30 - Closing Speech

17:50 - Evening Banquet

Dec.02_Part I

Dec.02_Part I

9:00 Conference Recap

9:05-9:20 Empowering China's Health Insurance Reform through Technology Innovation
Hengpeng ZHU Deputy Director, Institute of Economic Chinese Academy of Social Sciences

Session 5: Empowering Health Insurance and commercial Insurance Reform through Health Insurance Technology Innovation

09:25-09:45 Keynote Speech:
A New Generation of Healthcare Industry through Technology Transformation

Yiyu WU Head of the Healthcare Division, ZhongAn Technology

09:45-10:00 Keynote Speech:
Real Data Applications in Healthcare and Commercial Insurance Innovation

Zhi CHEN Co-founder, Shanghai Zechao Medical Technology

10:00-10:15 Keynote Speech:
Digitization of Health Care and Service Payments

Lin SHEN CEO,Founder, Youhujia

10:25-10:50 Case Study:
Practices of Insurtech - Cases from the Asia-Pacific Region

Ting JIANG Principal, Global Health and Development at Center for Advanced Hindsight, Duke University
Edward Booty CEO & Founder, Allied World Healthcare
Snehal Patel CEO & Founder, MyDoc
Abishek Shah CEO,Founder, Wellthy Therapeutics

10:50 - Tea Break
Session 6:Financing and Technological support for aging and Chronic Disease

11:05-11:20 Keynote Speech:
Global Experience:Chronic Disease and Aging Financing

Stephen Jan Head of the Health Economics and Process Evaluation Program, George Institute for Global Health

11:20-11:35 Multinational Pharma Giants: Accelerating Innovation to tackle the Impending Chronic Disease Pandemic
Xuan CUI Head of Market Access and Pricing, Merck

11:35-11:50 Keynote Speech:
Long Term Care in China: Data, Assessment, and Financing

Hansheng DING Deputy Director, Shanghai Health Development Research Center

11:50-12:35 Roundtable:
Financing and Payment: Promotion of Aging and Chronic Disease Management

Craig Anderson Executive Director, The George Institute, China
Lei ZHAO Pinetree Human Resource Director
Chunfang HUANG General Manager Health Care Department & Health Management Department, Taikang Pension Development Center
Zhijun WANG Deputy General Manager, China Life Property &Casualty Insurance Jiangxi Branch Office
Yong DING, Director, izhaohu
Lin SHEN CEO,Founder, Youhujia
Rebecca Ivers Head of school of public health in UNSW
Dale Huntington, Sc.D., Senior Director, Health Care Systems for Emerging Markets Asia Pacific, Johnson and Johnson

Dec.02_Part 2

Dec.02_Part 2

14:00-14:10 Opening Remarks:
Healthcare Data Analysis and Health Technology Assessment

Jie CHEN Director, Health Technology Assessment Research Center, Fudan University

Session 7: Health Payment and accessible innovation for Tumor and Rare Diseases

14:10-14:30 White Paper:
Raise the Availability and Affordability Rare Disease Medicines in China — Industry Research and Policy Suggestion

Qun LI Deputy Director, Healthcare and Finance Research Institute, Fudan Unviersity

14:30-14:50 Keynote Speech:
Exploring the Model of Care in Rare Diseases in China

Junshuai LIU Vice President,Qingdao Insurance Institute

14:50-15:10 Keynote Speech:
Health Impact Fund Mechanism and Its Impact on the Treatment of Cancer and Rare Diseases

Thomas Pogge Leitner Professor of Philosophy and International Affairs Founding Director of the Global Justice Program at Yale

15:10-15:55 Roundtable:
How can investment and payment innovations help to promote the accessibility of cancer and rare disease medicines for patients?

Junshuai LIU Vice President,Qingdao Insurance Institute
Yue XIAO Associate Professor, China National Health Development Research Center – Center for Health Policy Evaluation and Technology Assessment
Ramon Lyu Senior Director, Market Access Strategy & Payer Innovation Dept.
Lei XIAO Senior Adviser, Chinese Organization For Rare Disorders
Fei XIANG Chief BGI's Publicity Department, Committee Chief of Hua Foundation.
Jue WANG Founder, Liangyihui
Xin LI Vice President PingAN Insurance(Group)Company of China, Ltd.

3:45 - Tea Break
Session 8:Health Technology Assessment and Data Analysis

15:50-16:10 Keynote Speech:
Health Technology Assessment (HTA) in China: Current Practices and Future Directions

Kun ZHAO Division Director and Professor, China National Health Development Research Center – Center for Health Policy Evaluation and Technology Assessment

16:10-16:40 Keynote Speech:
Health Technology Assessment (HTA):Global Experiences and Best Practices

Yingyao CHEN Director, Key Lab of Health Technology Assessment, Ministry of Health, Fudan University School of Public Health

16:40-17:25 Roundtable:
Data Analysis,Health Technology Assessment and Value-based Healthcare

Yang XIE Senior Principal HEOR/RWE, IQVIA
Yue XIAO Associate Professor, China National Health Development Research Center – Center for Health Policy Evaluation and Technology Assessment
Huawei LUO Secretary General, Zhejiang Medical Association
Shaleen Khatri  Head of Programme Delivery Health and Life Science, China Prosperity Programme
Noah Friedman Senior Director Business Development & Strategy, Medtronic Greater China
Qinqin HUANG Business Unit Director,TK. CN Health Department

17:25-17:30 Closing Speech

FORUM AGENDA

Dec.01_Part I

Dec.01_Part I

09:00-09:20 Opening Remarks

Session 1: Health Insurance Reform:International and Domestic Experience Sharing

09:20-09:40 Keynote Speech:
Perfecting the Construction of a Multi-layered Health Insurance System
Jin FANG Deputy Secretary General, China Development Research Foundation

09:40-10:00 Keynote Speech:
Achieving Health Insurance Reform and Value-based Healthcare Implementation
Chunlin JIN Director Shanghai Health Development Research Center
(Shanghai Medical Technology Intelligence Institute)

10:00-10:15 Keynote Speech:
Universal Health Insurance Coverage
Eduardo P. Banzon Principal Health Specialist, Sustainable Development and Climate Change Department Asian Development Bank (ADB)

10:30-10:45 Keynote Speech:
Medicine Access Policy around the globe:Experience and Challenges for China
Silver CHEN Senior Director, Regional Access Lead – APAC/China at Pfizer

10:45AM - Tea Break
Session 2:Health Payment Innovation and Health Service System Upgrade

10:45-11:00 Keynote Speech:
Payment Innovation Promotes Chinese Health Service System Upgradation
Weiping GUO Chief Executive Officer and Executive Director, Universal Medical

11:00-11:15 Keynote Speech:
Experience Sharing:Healthcare System in Singapore
Jeremy LIM Partner & Head of Health & Life Sciences, Oliver Wyman, Asia Pacific, Chair of the Steering Committee for NIHA(NUS Initiative to Improve Health in Asia)

11:15-11:30 Keynote Speech:
Experience sharing:Taiwan's National Health Insurance and its Single-Payer System
Jui-fen Rachel Lu Professor, Chang Gung University

11:30-12:15 Roundtable:
How Can Commercial Health Insurance better Complement Social Insurance?
Wenkai LI Director and Chief Representative, China Medical Board (CMB) in Beijing Office
Zhen WANG Director, Department of Public Economics; Deputy Director, Center for Public Policy Research for Chinese Academy of Social Sciences (CASS)
Joshua Kurtzig Vice President for Healthcare Partnerships,United Family Healthcare
Lei LI General Manager,Strategic Operations Department of PKU Healthcare Group
Fujie XU Professor, The First Affiliated Hospital, Zhejiang University

12:35PM - Lunch

Dec.01_Part 2

Dec.01_Part 2

14:00-14:15 Opening Remarks
Session 3: Promotion of Innovation in health Finance and pharmaceutical industry

14:15-14:30 Keynote Speech:
Innovation and Upgrade of Health Financing under the backdrop of Health Insurance Reform
Xiaoyan XIA Partner& Managing Director,The Boston Consulting Group (BCG)

14:30-15:30 Roundtable:
With a focus on Health Financing and multi-channel collaboration to promote better Payment System for Patients< Xiaoyan XIA Partner& Managing Director,The Boston Consulting Group (BCG) Jim Maritan Senior Advisor, Shanghai MediTrust Health Co.,Ltd. Former CVS Vice President Yi LIANG Chief Bussiness Officer& President of the Great China Region,Zai Lab Limited Shaofeng CHEN Vice President, Business Unit Oncology 2,Roche Xudong FU President of China Market Access,Bristol-Myers Squibb Wang SHI Managing Director - MSD China Regional Operations Xiaojun SHAO Chief Medical Officer,China Pacific Insurance (Group) Co. Ltd.

3:50 - Tea Break
Session 4: Commercial Insurance Innovation and the Establishment of the Muti-layered Health Insurance System

15:30-15:45 Keynote Speech:
TBD
Jim Maritan Senior Advisor, Shanghai MediTrust Health Co.,Ltd. Former CVS Vice President

15:10-16:25 Keynote Speech:
Cooperation between Commercial Insurance Companies and Pharmaceutical Firms
Chu ZHANG Deputy General Manager, Actuarial Department, China Life Reinsurance Company Limited

16:25-17:15 Roundtable:
How can Commercial Insurance in China Supplement and Support Social Health Insurance to provide Universal and Affordable Healthcare?
Chu ZHANG Deputy General Manager, Actuarial Department, China Life Reinsurance Company Limited
Yan LI Chief Actuary, Huaxia Life Insurance Co., Ltd.
Shaohua CAO OP BU Head Eli Lilly and Company
Quanhua SONG Vice president Government & Corporate Business, China Pacific Life Insurance Co, Ltd. , President, Pacific Medical& Health Management Co, Ltd
Jiakang ZHU Franchise Head of Lung Cancer, Oncology BU at Astrazeneca
Baiyan CAO Chief Executive Officer& IOA,Jianyi Information technology Co. Ltd.

17:15-17:30 - Closing Speech

17:50 - Evening Banquet

Dec.02_Part I

Dec.02_Part I

09:00 Conference Recap

09:05-09:20 Empowering China's Health Insurance Reform through Technology Innovation
Hengpeng ZHU Deputy Director, Institute of Economic Chinese Academy of Social Sciences

Session 5: Empowering Health Insurance and commercial Insurance Reform through Health Insurance Technology Innovation

09:25-09:45 Keynote Speech:
A New Generation of Healthcare Industry through Technology Transformation
Yiyu WU Head of the Healthcare Division, ZhongAn Technology

09:45-10:00 Keynote Speech:
Real Data Applications in Healthcare and Commercial Insurance Innovation
Zhi CHEN Co-founder, Shanghai Zechao Medical Technology

10:00-10:15 Keynote Speech:
Digitization of Health Care and Service Payments
Lin SHEN CEO,Founder, Youhujia

10:25-10:50 Case Study:
Practices of Insurtech - Cases from the Asia-Pacific Region
Ting JIANG Principal, Global Health and Development at Center for Advanced Hindsight, Duke University
Edward Booty CEO & Founder, Allied World Healthcare
Snehal Patel CEO & Founder, MyDoc
Abishek Shah CEO,Founder, Wellthy Therapeutics

10:50 - Tea Break
Session 6:Financing and Technological support for aging and Chronic Disease

11:05-11:20 Keynote Speech:
Global Experience:Chronic Disease and Aging Financing
Stephen Jan Head of the Health Economics and Process Evaluation Program, George Institute for Global Health

11:20-11:35 Multinational Pharma Giants: Accelerating Innovation to tackle the Impending Chronic Disease Pandemic
Xuan CUI Head of Market Access and Pricing, Merck

11:35-11:50 Keynote Speech:
Long Term Care in China: Data, Assessment, and Financing
Hansheng DING Deputy Director, Shanghai Health Development Research Center

11:50-12:35 Roundtable:
Financing and Payment: Promotion of Aging and Chronic Disease Management
Craig Anderson Executive Director, The George Institute, China
Lei ZHAO Pinetree Human Resource Director
Chunfang HUANG General Manager Health Care Department & Health Management Department, Taikang Pension Development Center
Zhijun WANG Deputy General Manager, China Life Property &Casualty Insurance Jiangxi Branch Office
Yong DING, Director, izhaohu
Lin SHEN CEO,Founder, Youhujia
Rebecca Ivers Head of school of public health in UNSW
Dale Huntington, Sc.D., Senior Director, Health Care Systems for Emerging Markets Asia Pacific, Johnson and Johnson

Dec.02_Part 2

Dec.02_Part 2

14:00-14:10 Opening Remarks:
Healthcare Data Analysis and Health Technology Assessment

Jie CHEN Director, Health Technology Assessment Research Center, Fudan University

Session 7: Health Payment and accessible innovation for Tumor and Rare Diseases

14:10-14:30 White Paper:
Raise the Availability and Affordability Rare Disease Medicines in China — Industry Research and Policy Suggestion
Qun LI Deputy Director, Healthcare and Finance Research Institute, Fudan Unviersity

14:30-14:50 Keynote Speech:
Exploring the Model of Care in Rare Diseases in China

14:50-15:10 Keynote Speech:
Health Impact Fund Mechanism and Its Impact on the Treatment of Cancer and Rare Diseases
Thomas Pogge Leitner Professor of Philosophy and International Affairs Founding Director of the Global Justice Program at Yale

15:10-15:55 Roundtable:
How can investment and payment innovations help to promote the accessibility of cancer and rare disease medicines for patients?
Junshuai LIU Vice President,Qingdao Insurance Institute
Yue XIAO Associate Professor, China National Health Development Research Center – Center for Health Policy Evaluation and Technology Assessment
Ramon Lyu Senior Director, Market Access Strategy & Payer Innovation Dept.
Lei XIAO Senior Adviser, Chinese Organization For Rare Disorders
Fei XIANG Chief BGI's Publicity Department, Committee Chief of Hua Foundation.
Jue WANG Founder, Liangyihui
Xin LI Vice President PingAN Insurance(Group)Company of China, Ltd.

10:50 - Tea Break

Session 8:Health Technology Assessment and Data Analysis

15:50-16:10 Keynote Speech:
Health Technology Assessment (HTA) in China: Current Practices and Future Directions
Kun ZHAO Division Director and Professor, China National Health Development Research Center – Center for Health Policy Evaluation and Technology Assessment

16:10-16:40 Keynote Speech:
Health Technology Assessment (HTA):Global Experiences and Best Practices
Yingyao CHEN Director, Key Lab of Health Technology Assessment, Ministry of Health, Fudan University School of Public Health

16:40-17:25 Roundtable:
Data Analysis,Health Technology Assessment and Value-based Healthcare
Yang XIE Senior Principal HEOR/RWE, IQVIA
Yue XIAO Associate Professor, China National Health Development Research Center – Center for Health Policy Evaluation and Technology Assessment
Huawei LUO Secretary General, Zhejiang Medical Association
Shaleen Khatri  Head of Programme Delivery Health and Life Science, China Prosperity Programme
Noah Friedman Senior Director Business Development & Strategy, Medtronic Greater China
Qinqin HUANG Business Unit Director,TK. CN Health Department

17:25-17:30 Closing Speech

  • Healthcare financing innovation encompasses the continual improvement and reform of the social health insurance system, the collaboration between government and private entities to spearhead new initiatives and standards, as well as the creation of new value-based healthcare services and payments. Whatever form it may take on, healthcare financing helps to increase the accessibility of healthcare services and achieve lifelong healthcare management. Moreover, through artificial intelligence, finance technology and other novel techniques, product innovation in healthcare financing can deliver more precise and timely medical administration and services, increasing the quality and driving down the costs of healthcare.

    Chang Liu
    Chang Liu Managing Director of ACCESS Health Singapore, Mainland China, and Hong Kong
  • Fintech can go a long way to making healthcare better, cheaper and more responsive to patient needs. Fintech can contribute to better health coverage through innovative health insurance products and better calibration of premiums. It can improve the integrity of supply chains for drugs and medicines. New approaches can help transfer ownership of health data to individuals, empowering them in ways that has not been possible before. These are just a few examples. Governments across Asia need to catalyze and facilitate fintech as a tool for achieving high quality healthcare for all.

    Randeep Sudan
    Randeep Sudan Practice Manager for Information and Communication Technologies at the World Bank
  • Health and finance innovation conference is a high level conference exploring key opportunities at the intersection of fintech and health tech. We are bringing together people and partners from across sectors to envision healthcare of the future— one that is patient centered, high quality, affordable, and accessible. Hear from experts on real world health systems challenges and the innovative approaches that companies and governments are using to tackle them. Explore the role of deep technology in making health financing more secure and efficient. Meet like minded  individuals and organizations across industry, development, and government who are committed to outcomes and impact.

    William Haseltine
    William Haseltine Chairman and President of ACCESS Health International

TICKET & REGISTRATION

Early Bird Ticket

RMB 2,800(Evening Banquet Excluded)
RMB 3,500(Evening Banquet Included)

Standard Ticket

RMB 3,500(Evening Banquet Excluded)
RMB 4,200(Evening Banquet Included)

Group Ticket

Please Contact Forum  Planning  Committee for Group Purchasing
Email:contact@accessh.org.cn
Tel:+021 65053288

TICKET & REGISTRATION

Standard Ticket

RMB 3,500(Evening Banquet Excluded)
RMB 4,200(Evening Banquet Included)

Early Bird Ticket

RMB 2,800(Evening Banquet Excluded)
RMB 3,500(Evening Banquet Included)

Group Ticket

Please Contact Forum  Planning  Committee for Group Purchasing
Email:contact@accessh.org.cn
Tel:+021 65053288

VENUE & CONTACT INFO

Venue

Floor 2 Auditorium, Li Dasan Building,
School of Management, Fudan University

Contact Us

Chang Liu
Email: chang.liu@ accessh.org
Shu Shang:
Email: shu.shang@accessh.org
TEl:
+021 65053288

VENUE &
CONTACT INFO

Venue

Floor 2 Auditorium, Li Dasan Building,
School of Management, Fudan University

Contact Us

Chang Liu
Email: chang.liu@ accessh.org
Shu Shang:
Email: shu.shang@accessh.org
TEl:
+021 65053288